Gaby L. Longsworth, Ph.D., director at the intellectual property law firm Sterne, Kessler, Goldstein & Fox, discusses the recent U.S. Supreme Court decision in Limelight Networks, Inc. v. Akamai Technologies, Inc. She explains the patent issue at hand, outlines the Supreme Court's ruling, and provides more detail on the potential impact of the decision, particularly for pharmaceutical and medical diagnostic companies.

Embed Video

Copy

Topics:  Akamai Technologies, Direct Infringement, En Banc Review, Induced Infringement, Limelight Networks, Limelight v Akamai, Miniauction, Patent Infringement, Patent Litigation, SCOTUS

Published In: Intellectual Property Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Sterne, Kessler, Goldstein & Fox P.L.L.C. | Attorney Advertising